Convergence Investment Partners LLC increased its stake in shares of Tenet Healthcare Co. (NYSE:THC - Free Report) by 25.4% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 11,605 shares of the company's stock after buying an additional 2,351 shares during the quarter. Convergence Investment Partners LLC's holdings in Tenet Healthcare were worth $1,465,000 at the end of the most recent quarter.
A number of other hedge funds have also recently added to or reduced their stakes in the company. FMR LLC lifted its position in Tenet Healthcare by 88.0% in the third quarter. FMR LLC now owns 7,700,693 shares of the company's stock valued at $1,279,855,000 after purchasing an additional 3,604,161 shares during the period. Geode Capital Management LLC lifted its position in shares of Tenet Healthcare by 23.6% during the 3rd quarter. Geode Capital Management LLC now owns 2,044,667 shares of the company's stock valued at $339,893,000 after acquiring an additional 390,316 shares during the period. Franklin Resources Inc. lifted its position in shares of Tenet Healthcare by 11.9% during the 3rd quarter. Franklin Resources Inc. now owns 457,704 shares of the company's stock valued at $71,077,000 after acquiring an additional 48,580 shares during the period. Point72 Asset Management L.P. raised its position in shares of Tenet Healthcare by 32.0% during the 3rd quarter. Point72 Asset Management L.P. now owns 442,949 shares of the company's stock worth $73,618,000 after purchasing an additional 107,290 shares during the last quarter. Finally, Allspring Global Investments Holdings LLC raised its position in shares of Tenet Healthcare by 344.7% during the 3rd quarter. Allspring Global Investments Holdings LLC now owns 317,198 shares of the company's stock worth $52,718,000 after purchasing an additional 245,875 shares during the last quarter. Institutional investors and hedge funds own 95.44% of the company's stock.
Analysts Set New Price Targets
Several research analysts recently issued reports on THC shares. The Goldman Sachs Group downgraded Tenet Healthcare from a "buy" rating to a "neutral" rating and cut their price objective for the stock from $196.00 to $140.00 in a research report on Monday, December 16th. Wells Fargo & Company downgraded Tenet Healthcare from an "overweight" rating to an "equal weight" rating and cut their price objective for the stock from $205.00 to $150.00 in a research report on Monday, November 25th. StockNews.com downgraded Tenet Healthcare from a "buy" rating to a "hold" rating in a research report on Thursday, February 13th. Cantor Fitzgerald restated an "overweight" rating and set a $177.00 price objective on shares of Tenet Healthcare in a research report on Thursday, February 13th. Finally, UBS Group lifted their target price on shares of Tenet Healthcare from $197.00 to $217.00 and gave the stock a "buy" rating in a research note on Wednesday, October 30th. Four investment analysts have rated the stock with a hold rating, thirteen have given a buy rating and one has given a strong buy rating to the stock. According to MarketBeat, Tenet Healthcare presently has an average rating of "Moderate Buy" and an average price target of $163.19.
View Our Latest Stock Report on THC
Tenet Healthcare Stock Down 5.6 %
Shares of Tenet Healthcare stock traded down $7.67 during trading on Friday, reaching $129.57. The company had a trading volume of 1,741,974 shares, compared to its average volume of 1,340,176. The company has a market cap of $12.32 billion, a price-to-earnings ratio of 4.02, a price-to-earnings-growth ratio of 1.01 and a beta of 2.05. The firm's fifty day moving average is $132.90 and its 200-day moving average is $147.69. The company has a debt-to-equity ratio of 2.25, a quick ratio of 1.70 and a current ratio of 1.78. Tenet Healthcare Co. has a fifty-two week low of $88.98 and a fifty-two week high of $171.20.
Tenet Healthcare (NYSE:THC - Get Free Report) last issued its earnings results on Wednesday, February 12th. The company reported $3.44 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $2.95 by $0.49. Tenet Healthcare had a net margin of 15.48% and a return on equity of 21.88%. On average, analysts anticipate that Tenet Healthcare Co. will post 12.24 EPS for the current year.
About Tenet Healthcare
(
Free Report)
Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.
Read More

Before you consider Tenet Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tenet Healthcare wasn't on the list.
While Tenet Healthcare currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.